Home » Archive

Articles in the Pharma Category

News, Pharma »

[9 Dec 2009 | No Comment | ]

Pfizer (PFE) and Crown Bioscience, Inc. (Crown) announced today that they have entered into collaboration to research and develop novel therapeutics for Asian cancers. Specific treatments for Asian cancers represent an important unmet medical need as well as a significant market opportunity.

News, Pharma »

[19 Nov 2009 | No Comment | ]

Wockhardt, Pharmaceutical and biotechnology major launches anti-hypertensive drug Nicardipine injections in USA. Wockhardt announced that company has received United States Food & Drug Administration (US FDA) final approval for marketing Nicardipine HCl 25mg/10 ml injection, which is used for short-term management of hypertension or increased blood pressure.

News, Pharma »

[27 Sep 2009 | No Comment | ]
Strides Arcolab launches H1N1 swine flu drug ‘Starflu’

India head quartered global pharmaceutical company Strides Arcolab Limited (Strides) launched its anti-Swine Flu drug ‘Starflu’ and it’s available in Indian retail stores. Strides Arcolab’s Starflu is the generic version of H1N1 swine flu drug oseltamivir (Tamiflu) and its available in 75 mg capsules in a strip of 10’s, at a maximum retail price of Rs 460 per strip.

Pharma »

[19 Sep 2009 | No Comment | ]

Glenmark Generics Limited received ANDA approval for Verapamil 240mg which is indicated for management of essential. Verapamil SR tablets are the generic equivalent of Isoptin SR tablets. Verapamil 240mg has strength of more than half the market share of the overall Verapamil SR product line. The total sale for the twelve month period ending June 2009 was USD 65 million, according to IMS Health.
Verapamil is used to treat hypertension (high blood pressure), angina (chest pain). This is used for some certain heart rhythm disorders. Verapamil’s mechanism in all cases is …

Featured, Headline, News, Pharma »

[6 Jul 2009 | No Comment | ]
Apollo Children’s Hospital perform a complicated intracardiac repair of complete A-V canal defect

The Pediatric Cardiac team at the new Apollo Children’s Hospital successfully performed a complicated surgery to treat a condition called complete a-v canal defect in a 4–month old Nigerian baby.
 
Speaking at the press briefing alongside the patient, Dr. Neville Solomon, Pediatric Cardiac Surgeon & Dr. Muthukumaran, Pediatric Cardiologist said, “The Nigerian baby was ailing with a condition called complete a-v canal defect. This consists of two holes in the heart with mitral and tricuspid valves possibly leaky as well. The child also has Down’s syndrome, which makes the surgery even …

News, Pharma »

[23 Apr 2009 | No Comment | ]

Metastatic Breast Cancer Patient Survey found that most (78 percent) women living with metastatic breast cancer (MBC) have never participated in a clinical trial. Of these women, more than half (56 percent) were never invited to consider a clinical trial and one-third (30 percent) had not been recommended a clinical trial by their healthcare provider.

News, Pharma »

[13 Apr 2009 | No Comment | ]

US drug maker Pfizer Inc, announced on Sunday that it will make a tender offer to acquire a 33.77% stake in Pfizer Limited from public shareholders at a price of Rs. 675.00 per share. The offer will represent a total value of up to Rs. 6.8 billion, or approximately $ 136 million.

News, Pharma »

[6 Apr 2009 | No Comment | ]

Narayana Hrudayalaya, the leader in providing world class healthcare at affordable prices, has extended its portfolio yet again. The Mazumdar Shaw Centre for Cancer Research commissioned for late April is set to be the world’s largest cancer hospital at 5 Lac sq ft after an investment of approximately 250 crore.

Pharma »

[14 Mar 2009 | No Comment | ]

A new global survey of 950 women living with metastatic breast cancer (MBC) in nine countries (the United Kingdom, France, Spain, Belgium, Poland, the United States, Argentina, Egypt and Mexico) found that despite the negative impact of their disease, a majority still enjoy life and desire public attention that recognizes their unique experiences. Based on the survey results, the international committee of experts overseeing the survey advocate tailored education programs to raise awareness of the needs of women with MBC. Results from this survey, which was conducted by Harris Interactive® …